Oliver Lagore Vanvalin Investment Group Sarepta Therapeutics, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 90 shares of SRPT stock, worth $9,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90
Previous 90
-0.0%
Holding current value
$9,408
Previous $14,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
532Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.08 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$937 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$654 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$456 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$446 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.15B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...